<i>JAMA Dermatology—</i>The Year in Review, 2021

Shinkai, Kanade

doi:10.1001/jamadermatol.2022.0110

JAMA Dermatol

2022

DOI: 10.1001/jamadermatol.2022.0110

|View full text |Cite

JAMA Dermatology—The Year in Review, 2021

Kanade Shinkai

Abstract: An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…I personally thank the entire editorial team, all of the authors and reviewers who contributed their time and expertise, and our readers for their sustained contributions to the journal and its educational mission. With the return of national and international in-person meetings, hopefully this upcoming year will bring more opportunities for connection and reintegration to the members of this specialty.…”

mentioning

confidence: 99%

JAMA Dermatology—The Year in Review, 2022

Shinkai

2023

JAMA Dermatol

Self Cite

View full text Add to dashboard Cite

JAMA Dermatology continued to thrive in 2022. The editorial leadership team carefully evaluated 2745 article submissions during the past year (Table ).A total of 1300 of 2745 submissions (47%) were research articles, which was similar to the previous year. Acceptance rates also remained stable, with 10% of submissions overall and 11% of research articles accepted for publication. With an ongoing commitment to pub-lishing excellence and process improvement, the journal continued to maintain its goal of reducing the time to publication, keeping the median days of acceptance to publication to 61 days while offering timely editorial decisions, including maintaining its median receipt-to-rejection time of 4 days and median receipt to first decision with peer review of 42 days. The editorial leadership team continued to strive to find ways to improve authors' experience to ensure authors the fastest and best publication of their work. As predicted in last year's review, many of the top dermatology journals achieved substantial increases in impact factors, which was likely a reflection of COVID-19 skinrelated publications, and in line with trends seen across the medical literature. JAMA Dermatology's impact factor increased from 10.3 to 11.8.The journal broadened its digital reach, with more than 5.2 million full-text views and downloads in the past year (an approximately 20% increase), and expanded its connections to more than 68 000 followers on the social media channels Twitter, Facebook, and Instagram, a 15% increase compared with the

show abstract

mentioning

confidence: 99%

JAMA Dermatology—The Year in Review, 2022

Shinkai

2023

JAMA Dermatol

Self Cite

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

JAMA Dermatology—The Year in Review, 2021

Abstract: An inverse stage-shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID-19 pandemic.

Cited by 1 publication

References 18 publications

JAMA Dermatology—The Year in Review, 2022

JAMA Dermatology—The Year in Review, 2022

Contact Info

Product

Resources

About